DOI QR코드

DOI QR Code

Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation

  • Kim, Su Min (Department of Biomedical Laboratory Science, Konyang University) ;
  • Ha, Ji Sun (Department of Biomedical Laboratory Science, Konyang University) ;
  • Han, A Reum (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine) ;
  • Cho, Sung-Woo (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine) ;
  • Yang, Seung-Ju (Department of Biomedical Laboratory Science, Konyang University)
  • Received : 2019.01.25
  • Accepted : 2019.02.12
  • Published : 2019.10.31

Abstract

Microglial cells are known as the main immune cells in the central nervous system, both regulating its immune response and maintaining its homeostasis. Furthermore, the antioxidant ${\alpha}-lipoic$ acid (LA) is a recognized therapeutic drug for diabetes because it can easily invade the blood-brain barrier. This study investigated the effect of ${\alpha}-LA$ on the inflammatory response in lipopolysaccharide (LPS)-treated BV-2 microglial cells. Our results revealed that ${\alpha}-LA$ significantly attenuated several inflammatory responses in BV-2 microglial cells, including pro-inflammatory cytokines, such as tumor necrosis $factor-{\alpha}$ and interleukin (IL)-6, and other cytotoxic molecules, such as nitric oxide and reactive oxygen species. In addition, ${\alpha}-LA$ inhibited the LPS-induced phosphorylation of ERK and p38 and its pharmacological properties were facilitated via the inhibition of the nuclear factor kappa B signaling pathway. Moreover, ${\alpha}-LA$ suppressed the activation of NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasomes, multiprotein complexes consisting of NLRP3 and caspase-1, which are involved in the innate immune response. Finally, ${\alpha}-LA$ decreased the genes accountable for the M1 phenotype, $IL-1{\beta}$ and ICAM1, whereas it increased the genes responsible for the M2 phenotype, MRC1 and ARG1. These findings suggest that ${\alpha}-LA$ alleviates the neuroinflammatory response by regulating microglial polarization.

Keywords

References

  1. Shi H, Sheng B, Zhang F et al (2013) Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am J Physiol Heart Circ Physiol 304, H796-805 https://doi.org/10.1152/ajpheart.00712.2012
  2. Cunha C, Gomes C, Vaz AR and Brites D (2016) Exploring new inflammatory biomarkers and pathways during LPS-Induced M1 polarization. Mediators Inflamm 2016, 6986175
  3. Orihuela R, McPherson CA and Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173, 649-665 https://doi.org/10.1111/bph.13139
  4. Bauernfeind FG, Horvath G, Stutz A et al (2010) NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183, 787-791 https://doi.org/10.4049/jimmunol.0901363
  5. Jo EK, Kim JK, Shin DM and Sasakawa C (2016) Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 13, 148-159 https://doi.org/10.1038/cmi.2015.95
  6. Thirunavukkarasu V, Anitha Nandhini AT and Anuradha CV (2004) Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol B 174, 587-592 https://doi.org/10.1007/s00360-004-0447-z
  7. Kamenova P (2006) Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens) 5, 251-258 https://doi.org/10.14310/horm.2002.11191
  8. Maczurek AE, Ooi L, Patel M and Munch G (2013) Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Nat Med Nutraceuticals Neurocognition 60, 71-88
  9. Brown GC and Vilalta A (2015) How microglia kill neurons. Brain Res 1628, 288-297 https://doi.org/10.1016/j.brainres.2015.08.031
  10. Qureshi GA, Baig S, Sarwar M and Parvez SH (2004) Neurotoxicity, oxidative stress and cerebrovascular disorders. Neurotoxicology 25, 121-138 https://doi.org/10.1016/S0161-813X(03)00093-7
  11. Chen L, Na R, Boldt E and Ran Q (2015) NLRP3 inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure. Neurobiol Aging 36, 2533-2543 https://doi.org/10.1016/j.neurobiolaging.2015.05.018
  12. Chew LJ, Takanohashi A and Bell M (2006) Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12, 105-112 https://doi.org/10.1002/mrdd.20102
  13. Sorbara MT and Girardin SE (2011) Mitochondrial ROS fuel the inflammasome. Cell Res 21, 558-560 https://doi.org/10.1038/cr.2011.20
  14. Yang JW, Yang SJ, Na JM, Hahn HG and Cho SW (2018) 3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates NLRP3 inflammasome-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglial cells. Biochem Biophys Res Commun 495, 151-156 https://doi.org/10.1016/j.bbrc.2017.10.131
  15. Walsh JG, Muruve DA and Power C (2014) Inflammasome in the CNS. Nat Rev Neuroeci 15, 84-97 https://doi.org/10.1038/nrn3638
  16. Fan HH, Zhu LB, Li T et al (2017) Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and $NF{\kappa}B$ pathways. Int Immunopharmacol 50, 14-21 https://doi.org/10.1016/j.intimp.2017.06.004
  17. Yang XW, Li YH, Zhang H et al (2016) Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int J Immunopathol Pharmacol 29, 54-64 https://doi.org/10.1177/0394632015617065
  18. Kim EA, Han AR, Choi J, Ahn JY, Choi SY and Cho SW (2014) Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells. Int Immunopharmacol 22, 73-83 https://doi.org/10.1016/j.intimp.2014.06.022
  19. Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14, 388-405 https://doi.org/10.1016/S1474-4422(15)70016-5
  20. Tremblay ME and Sierra A (2014) Microglia in health and disease. Microglia Heal Dis 313, 1-486
  21. Kim SH, Oh K, Jin HK and Bae J (2018) Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases. BMB Rep 51, 545-546 https://doi.org/10.5483/BMBRep.2018.51.11.255
  22. Samstad EO, Niyonzima N, Nymo S et al (2014) Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 192, 2837-2845 https://doi.org/10.4049/jimmunol.1302484
  23. Yang SJ, Kim J, Lee S et al (2017) Anti-inflammatory and anti-oxidative effects of on beta-amyloid-induced microglial activation. BMB Rep 50, 634-639 https://doi.org/10.5483/BMBRep.2017.50.12.189